Imran Qureshi, M.D.
Addiction Psychiatry Physician in Staten Island, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 683 in Addiction Psychiatry Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Imran Qureshi, M.D. reported a CMS MIPS final score of 91.3/100 - above the 83.5 national average - and filed 418 Medicare Part D claims in 2024.
- 91.3/100
- MIPS score · +8 vs avg
- 418
- Part D claims, 2024
- 95%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Imran Qureshi, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1336553999), first enumerated 06/11/2014.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 418 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 91.3/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Imran Qureshi, M.D.'s individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1336553999 · Addiction Psychiatry Physician
NPI-10 · ENUM-MID · TAX-NARROW · MIPS-ABOVE · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1336553999
- ENUM-MID 2014
- TAX-NARROW 683
- MIPS-ABOVE 91.3/100
- RX-LIGHT 418
- BOOK-THIN 94 in New York
- PHOTO-FINISH Alan Swann, M.D. · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Elizabeth Cookso…
Elizabeth Cookson, M.D.
91.1 MIPS pts
- Danielle Patters…
Danielle Patterson, M.D.
91.2 MIPS pts
- Qureshi · this p…
Qureshi · this provider
91.3 MIPS pts
- Alan Swann, M.D.…
Alan Swann, M.D.
91.3 MIPS pts
- Iyengar Malini, …
Iyengar Malini, M.D.
91.5 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Imran Qureshi, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
91 ≥ 61st percentile 61% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Imran Qureshi, M.D. sits
This provider among addiction psychiatry physician peers
Across the 73 addiction psychiatry physician providers who report both Medicare Part D prescribing and a MIPS quality score, Imran Qureshi, M.D. writes more Part D claims than 66% of them and scores higher on MIPS quality than 58% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one addiction psychiatry physician peer from a representative sample of 60; the gold marker is Imran Qureshi, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Imran Qureshi, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Imran Qureshi, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New York
How Addiction Psychiatry Physician compares to other specialties among New York providers
Addiction Psychiatry Physician ranks #221 among New York's specialties (0% of in-state providers)
Each bar is a specialty's share of the New York provider total, by primary NUCC taxonomy. The highlighted bar is Addiction Psychiatry Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Imran Qureshi, M.D.'s 2023 MIPS final score plotted against the Addiction Psychiatry Physician national average
- MIPS Final Score
- 91.3/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Specialty volume Addiction Psychiatry Physician US NPIs
91.3/100 MIPS final score - 7.8 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Addiction Psychiatry Physician. Quality dim: 74.9.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1336553999 |
|---|---|
| Specialty | Addiction Psychiatry Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/11/2014 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Imran Qureshi, M.D.'s current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1336553999 is the unique 10-digit identifier CMS uses to link Qureshi across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Imran Qureshi, M.D.. To verify Imran Qureshi, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
5% brand-name claims vs 95% generic, on 418 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 430
- Total Day Supply
- 12,276
- Brand vs Generic
- 5% brand / 95% generic
- Brand Drug Cost
- $7K
- Generic Drug Cost
- $7K
Patient Demographics
- Average Patient Age
- 63.2 years
- Avg HCC Risk Score
- 1.59
- Gender Split
- 50% female / 50% male
- Age Distribution
- <65: 11, 65-74: 12, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Imran Qureshi, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Sertraline Hcl
Sertraline Hcl
107 claims
- Buprenorphine-Nalo…
Buprenorphine-Naloxone
50 claims
- Quetiapine Fumarate 36
Quetiapine Fumarate
36 claims
- Escitalopram Oxalate 30
Escitalopram Oxalate
30 claims
- Mirtazapine 29
Mirtazapine
29 claims
- Trazodone Hcl 27
Trazodone Hcl
27 claims
- Suboxone 22
Suboxone
22 claims
- Gabapentin 17
Gabapentin
17 claims
| Drug | Claims |
|---|---|
| Sertraline Hcl | 107 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 50 |
| Quetiapine Fumarate | 36 |
| Escitalopram Oxalate | 30 |
| Mirtazapine | 29 |
| Trazodone Hcl | 27 |
| Suboxone Buprenorphine Hcl/Naloxone Hcl | 22 |
| Gabapentin | 17 |
| Lamotrigine | 15 |
| Buspirone Hcl | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Addiction Psychiatry Physician Overview
How Imran Qureshi, M.D. fits within the Addiction Psychiatry Physician landscape nationally.
Imran Qureshi, M.D.'s 418 claims are below the specialty average of 789.
Nationwide Addiction Psychiatry Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Qureshi, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (91.3 here).
Same NPPES enumeration year (2014)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Addiction Psychiatry Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Qureshi.
One of 94 Addiction Psychiatry Physician providers enrolled in New York, 5 are shown here.
Compare Addiction Psychiatry Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Imran Qureshi, M.D.'s specialty? ▼
How much does Imran Qureshi, M.D. prescribe under Medicare Part D? ▼
What is Imran Qureshi, M.D.'s Medicare quality score? ▼
Where is Imran Qureshi, M.D. located? ▼
What is Imran Qureshi, M.D.'s NPI number? ▼
Does Imran Qureshi, M.D. prescribe more brand-name or generic drugs? ▼
How many Addiction Psychiatry Physician providers are there in the US? ▼
What drugs does Imran Qureshi, M.D. prescribe most often? ▼
Does Imran Qureshi, M.D. accept Medicare? ▼
How can I verify Imran Qureshi, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.